Law360 Recognizes Robbins Geller as One of the Nation’s Most Feared Plaintiffs’ Firms for 2015
For the third year in a row, Robbins Geller was named to Law360’s Most Feared Plaintiffs Firms of 2015 list. Law360 focused on firms that have “won some of the largest and most impactful judgments and settlements over the past year.” While a more detailed article will be published on the Firm and its recent successes in the next couple of weeks, the publication commended Robbins Geller for obtaining over “$590 million in a series of settlements in a class action claiming Goldman Sachs Group Inc., Carlyle Group LP and several other private equity firms teamed up to keep leveraged buyout prices low.” The Private Equity case altered the way private equity firms do business and is the largest antitrust class action settlement in which no civil or criminal government action was taken.
Another notable victory from the past year includes a $400 million recovery obtained for shareholders in the Pfizer Inc. securities class action that settled days before trial. The case arose out of an agreement to settle certain off-label marketing investigations in the early 2000s. Although Pfizer and its officers have insisted publicly that the company itself did not engage in off-label promotion, Pfizer was alleged to have illegally promoted several of its own drugs off label to boost sales.
The Law360 recognition comes on the heels of numerous accolades conferred upon the Firm and its attorneys this year, including a top ranking by The National Law Journal for its second annual list of America’s Elite Trial Lawyers. Additionally, Robbins Geller was named a top plaintiff firm by The Legal 500, a national Tier 1 “Best Law Firm” by U.S.News – Best Lawyers® and a Band 1 firm by Chambers USA.
Read More Awards
- Partner Aelish Marie Baig Recognized as 2023 Plaintiffs’ Lawyers Trailblazer by The National Law JournalMay 2, 2023
- Robbins Geller Ranked Top Securities Law Firm for the Third Year in a Row by Institutional Shareholder ServicesFebruary 28, 2023
- January 26, 2023
- January 19, 2023
- October 14, 2022